Novel drug synergism. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Cell Line Cells, Cultured Tumor Cells, Cultured Brain

Organisms12

Mice, Nude Mycobacterium tuberculosis Mice, Inbred C57BL Mice, Inbred BALB C Mice, SCID Plasmodium falciparum Trichoderma Mice, Knockout Enterococcus faecalis Rats, Sprague-Dawley Gram-Negative Anaerobic Straight, Curved, and Helical Rods Bacteria

Diseases3

Disease Models, Animal Neoplasms Multiple Myeloma

Chemicals and Drugs55

Antineoplastic Agents Drugs, Investigational Drug Carriers Small Molecule Libraries Anti-Bacterial Agents Pharmaceutical Preparations Enzyme Inhibitors Antiprotozoal Agents Recombinant Proteins Indoles Ligands Gentamicins Receptors, G-Protein-Coupled Proteome Boronic Acids Bacterial Proteins Anti-Inflammatory Agents Antitubercular Agents Antineoplastic Agents, Phytogenic Doxorubicin Aminoglycosides Peptides Antiviral Agents Protein Kinase Inhibitors RNA, Messenger Cellulase Oxyfedrine Drug Combinations Protozoan Proteins RNA, Small Interfering Cellulose 1,4-beta-Cellobiosidase Proteins Transcription Factors Streptomycin Kanamycin DNA-Binding Proteins Tobramycin Cellulose Trifluridine Penicillins Peptaibols Thiomalates Carbenicillin Ampicillin Phosmet Propolis Dimethoate Antifungal Agents Polymyxins Sulfamethoxazole Tumor Necrosis Factor-alpha Cisplatin Fosfomycin Fluconazole Azlocillin

Analytical, Diagnostic and Therapeutic Techniques and Equipment27

Drug Discovery Drug Delivery Systems Drug Design Drug Evaluation, Preclinical Drug Repositioning Molecular Targeted Therapy Drug Carriers Disease Models, Animal Microbial Sensitivity Tests High-Throughput Screening Assays Inhibitory Concentration 50 Models, Biological Molecular Docking Simulation Models, Molecular Drug Screening Assays, Antitumor Clinical Trials as Topic Gene Expression Profiling Xenograft Model Antitumor Assays Oligonucleotide Array Sequence Analysis Cloning, Molecular Reverse Transcriptase Polymerase Chain Reaction Drug Therapy, Combination Sequence Alignment Crystallography, X-Ray Reproducibility of Results Antineoplastic Combined Chemotherapy Protocols Lethal Dose 50

Phenomena and Processes37

Drug Synergism Dose-Response Relationship, Drug Signal Transduction Cell Survival Apoptosis Inhibitory Concentration 50 Cell Proliferation Protein Binding Amino Acid Sequence Molecular Structure Time Factors Mutation Binding Sites Drug Resistance, Neoplasm Kinetics Gene Expression Regulation Drug Antagonism Base Sequence Protein Structure, Tertiary Cell Cycle Structure-Activity Relationship Algorithms Gene Expression Gene Expression Regulation, Neoplastic Enzyme Activation Substrate Specificity Particle Size Drug Interactions Phenotype Promoter Regions, Genetic Sequence Homology, Amino Acid Transcription, Genetic Penicillin Resistance Lethal Dose 50 Transcriptional Activation Protein Conformation Phylogeny

Disciplines and Occupations5

Drug Discovery Drug Design Chemistry, Pharmaceutical Computational Biology Proteomics

Technology, Industry, Agriculture3

Nanoparticles Drug Industry Cellulose

Information Science7

Molecular Sequence Data Molecular Docking Simulation Amino Acid Sequence Base Sequence Algorithms Computer Simulation Phylogeny

Health Care2

Clinical Trials as Topic Reproducibility of Results

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Drug Synergism Drug Discovery Drug Delivery Systems Drug Design Drug Evaluation, Preclinical Drug Repositioning Antineoplastic Agents Molecular Targeted Therapy Drugs, Investigational Drug Carriers Small Molecule Libraries Cell Line, Tumor Dose-Response Relationship, Drug Anti-Bacterial Agents Pharmaceutical Preparations Signal Transduction Disease Models, Animal Molecular Sequence Data Enzyme Inhibitors Cell Survival Microbial Sensitivity Tests Apoptosis Cell Line High-Throughput Screening Assays Nanoparticles Inhibitory Concentration 50 Antiprotozoal Agents Models, Biological Molecular Docking Simulation Drug Industry Cell Proliferation Cells, Cultured Protein Binding Tumor Cells, Cultured Amino Acid Sequence Molecular Structure Neoplasms Chemistry, Pharmaceutical Models, Molecular Drug Screening Assays, Antitumor Time Factors Mutation Recombinant Proteins Binding Sites Clinical Trials as Topic Drug Resistance, Neoplasm Gene Expression Profiling Mice, Nude Indoles Ligands Gentamicins Mycobacterium tuberculosis Receptors, G-Protein-Coupled Proteome Mice, Inbred C57BL Kinetics Boronic Acids Bacterial Proteins Anti-Inflammatory Agents Gene Expression Regulation Drug Antagonism Base Sequence Antitubercular Agents Mice, Inbred BALB C Computational Biology Xenograft Model Antitumor Assays Antineoplastic Agents, Phytogenic Doxorubicin Aminoglycosides Protein Structure, Tertiary Cell Cycle Peptides Antiviral Agents Protein Kinase Inhibitors RNA, Messenger Cellulase Structure-Activity Relationship Algorithms Multiple Myeloma Oligonucleotide Array Sequence Analysis Gene Expression Cloning, Molecular Gene Expression Regulation, Neoplastic Oxyfedrine Drug Combinations Protozoan Proteins RNA, Small Interfering Mice, SCID Reverse Transcriptase Polymerase Chain Reaction Cellulose 1,4-beta-Cellobiosidase Enzyme Activation Substrate Specificity Plasmodium falciparum Trichoderma Particle Size Proteins Drug Interactions Computer Simulation Drug Therapy, Combination Transcription Factors

No FAQ available that match "novel drug synergism"